Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diarrhoea in the traveller].

M M Alonso Socas1, R Alemán, A López Lirola

  • 1Sección de Infecciones, Servicio de Medicina Interna, Hospital Universitario de Canarias, Tenerife, Spain.

Anales Del Sistema Sanitario De Navarra
|May 25, 2006
PubMed
Summary

Traveler's diarrhea, a common illness from contaminated food and water, affects 50,000 daily. Prevention focuses on hygiene, while new drugs like Rifaximine offer treatment options, especially for resistant infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ab Initio Phase Diagram of Gold in Extreme Conditions.

Physical review letters·2023
Same author

[Bacterial arthritis' clinical suspicion in an HIV patient].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021
Same author

Role of Functional Imaging Techniques to Assess Motor and Language Cortical Plasticity in Glioma Patients: A Systematic Review.

Neural plasticity·2019
Same author

Comparison of T1 mapping and fixed T1 method for dynamic contrast-enhanced MRI perfusion in brain gliomas.

European radiology·2019
Same author

Longitudinal quantitative magnetic resonance imaging in adrenomyeloneuropathy.

European journal of neurology·2019
Same author

Dexamethasone-induced upregulation of Ca<sub>V</sub>3.2 T-type Ca<sup>2+</sup> channels in rat cardiac myocytes.

The Journal of steroid biochemistry and molecular biology·2017

Area of Science:

  • Infectious Diseases
  • Public Health
  • Travel Medicine

Context:

  • Diarrhoeic diseases remain a significant health concern in developing regions, impacting global travelers.
  • Approximately 50,000 cases of traveler's diarrhea occur daily worldwide, primarily affecting those returning from less developed areas.
  • Destination significantly influences risk and etiology, with bacterial infections being the most prevalent cause.

Purpose:

  • To review the epidemiology, etiology, and management of diarrhoeic diseases in travelers.
  • To highlight prevention strategies, including hygiene and judicious antibiotic use.
  • To discuss current treatment options and the role of newer agents like Rifaximine.

Summary:

  • Bacterial pathogens cause 60-85% of traveler's diarrhea cases; parasites account for 10% and viruses for 5%.

Related Experiment Videos

  • While typically benign, complications can occur. Prevention relies on strict hygiene and avoiding contaminated food/water.
  • Antibiotic prophylaxis is reserved for high-risk, short-duration travel, particularly for immunocompromised individuals.

    • Impact:

    • Effective management and prevention strategies are crucial for reducing morbidity associated with traveler's diarrhea.
    • Understanding regional variations in etiology is key for targeted prevention and treatment.
    • The introduction of Rifaximine provides a valuable therapeutic option, especially in regions with quinolone-resistant enteropathogens.